J Langhorst1, P Heldmann2, P Henningsen3, K Kopke4, L Krumbein5, H Lucius6, A Winkelmann7, B Wolf8, W Häuser3,9. 1. Innere Medizin V (Naturheilkunde und integrative Medizin), Kliniken Essen-Mitte, Essen, Deutschland. j.langhorst@kliniken-essen-mitte.de. 2. Bundesverband selbstständiger Physiotherapeuten, Bochum, Deutschland. 3. Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Technische Universität München, München, Deutschland. 4. Department Pflege und Management, Hochschule für angewandte Wissenschaft Hamburg, Hamburg, Deutschland. 5. RehaKlinikum Bad Säckingen, Bad Säckingen, Deutschland. 6. Schmerzambulanz, Helios-Fachklinik Schleswig, Schleswig, Deutschland. 7. Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation, Klinikum der Universität München, München, Deutschland. 8. Deutsche Fibromyalgie Vereinigung, Seckach, Deutschland. 9. Innere Medizin I, Klinikum Saarbrücken gGmbH, Saarbrücken, Deutschland.
Abstract
BACKGROUND: The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. METHODS: The guidelines were developed by 13 scientific societies and 2 patient self-help organizations coordinated by the German Pain Society. Working groups (n =8) with a total of 42 members were formed balanced with respect to gender, medical expertise, position in the medical or scientific hierarchy and potential conflicts of interest. A search of the literature for systematic reviews of randomized controlled trials of complementary and alternative therapies from December 2010 to May 2016 was performed in the Cochrane library, MEDLINE, PsycINFO and Scopus databases. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine version 2009. The strength of recommendations was formed by multiple step formalized procedures to reach a consensus. Efficacy, risks, patient preferences and applicability of available therapies were weighed up against each other. The guidelines were reviewed and approved by the board of directors of the societies engaged in the development of the guidelines. RESULTS AND CONCLUSION: Meditative movement therapies (e.g. qi gong, tai chi and yoga) are strongly recommended. Acupuncture and weight reduction in cases of obesity can be considered.
BACKGROUND: The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. METHODS: The guidelines were developed by 13 scientific societies and 2 patient self-help organizations coordinated by the German Pain Society. Working groups (n =8) with a total of 42 members were formed balanced with respect to gender, medical expertise, position in the medical or scientific hierarchy and potential conflicts of interest. A search of the literature for systematic reviews of randomized controlled trials of complementary and alternative therapies from December 2010 to May 2016 was performed in the Cochrane library, MEDLINE, PsycINFO and Scopus databases. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine version 2009. The strength of recommendations was formed by multiple step formalized procedures to reach a consensus. Efficacy, risks, patient preferences and applicability of available therapies were weighed up against each other. The guidelines were reviewed and approved by the board of directors of the societies engaged in the development of the guidelines. RESULTS AND CONCLUSION: Meditative movement therapies (e.g. qi gong, tai chi and yoga) are strongly recommended. Acupuncture and weight reduction in cases of obesity can be considered.
Authors: V Köllner; K Bernardy; W Greiner; L Krumbein; H Lucius; M Offenbächer; M Sarholz; M Settan; W Häuser Journal: Schmerz Date: 2017-06 Impact factor: 1.107
Authors: A Avenell; J Broom; T J Brown; A Poobalan; L Aucott; S C Stearns; W C S Smith; R T Jung; M K Campbell; A M Grant Journal: Health Technol Assess Date: 2004-05 Impact factor: 4.014
Authors: John C Deare; Zhen Zheng; Charlie C L Xue; Jian Ping Liu; Jingsheng Shang; Sean W Scott; Geoff Littlejohn Journal: Cochrane Database Syst Rev Date: 2013-05-31